Monkeypox in Group B of infectious disease in Vietnam
he Ministry of Health has added monkeypox to the Group B infectious diseases with other dangerous, infectious diseases capable of spreading quickly and possibly causing death.
A Ministry of Health official inspects the prevention of monkeypox at Hanoi Dermatology Hospital. (Photo: VNA)
Hanoi (VNA) - The Ministry of Health has added monkeypox to theGroup B infectious diseases with other dangerous, infectious diseases capableof spreading quickly and possibly causing death.
Decision No. 3044/QD-BYT, issued on November 9, is based on the ministry'sDepartment of Preventive Medicine proposal.
Disease prevention and control activities are carried out following the Law onPrevention and Control of Infectious Diseases and based on monkeypox'sdangerous nature, transmissibility and mortality rate.
The situation of the monkeypox epidemic in the world is still complicated. Vietnamhas also recorded several positive cases returning from abroad.
Monkeypox was first reported in 1958 in monkeys raised for research.
Since May 2022, the epidemic has developed abnormally, spreading to manycountries.
The incubation period is usually from six to thirteen days. Symptoms may vary,depending on the stage of the disease, but are similar to smallpox.
Common symptoms of monkeypox include fever, headache, muscle pain, back pain,swollen lymph nodes, chills, fatigue, and a rash that looks like blisters onthe face or inside of the mouth or in other parts of the body, such as thehands, feet, chest, genitals, or anus.
The disease can clear up on its own within 2-3 weeks.
In Vietnam, infectious diseases are classified into three groups./.
A woman returning from Dubai has tested positive for monkeypox, making her the second case detected in Vietnam, reported the Ho Chi Minh City’s Department of Health on October 20.
As the second monkeypox patient was put under quarantine upon her arrival at Tan Son Nhat airport in Ho Chi Minh City, she did not come into contact with anyone in the community, hence a zero risk of community infection, a health official confirmed.
The second patient with monkeypox in Vietnam was discharged from hospital on October 31 after two weeks of treatment, according to Ho Chi Minh City Hospital for Tropical Diseases.
The General Department of Preventive Medicine under the Ministry of Health on November 3 sent a document to the Health Department of the Central Highlands province of Dak Lak, asking it to step up monkeypox prevention and control.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.